NHS Blood and Transplant (NHSBT) is still appealing to people in Birmingham to donate convalescent plasma if they have recovered from COVID-19.
This has been illustrated through an infographic posted on the social media pages of the Ministry of Public Health (MoPH), HMC and Primary Health Care Corporation.
This treatment involves taking plasma taken from patients who have recovered from COVID-19 and transfusing it into patients now battling the virus.
University Hospitals has added convalescent plasma donations to its experimental treatment of COVID-19, participating in a study to determine the effects of the treatment.
Once a person recovered the antibodies stay in their body to fight the virus if it returns.
HMC is using state-of-the-art treatment options for patients with COVID-19 who are now under its care and one treatment uses the blood plasma of recovered COVID-19 patients. One transfusion is enough to see results.
More than 40 coronavirus survivors from Birmingham have so far booked to donate plasma.
"The treatment is being used on Covid-19 patients in Qatar".
On the Mayo Clinic Q&A podcast, Dr. Philippe Bauer, site principal investigator for Mayo Clinic in Rochester, discusses the COVID-19 convalescent plasma program.